CurrentEndo
Get Weekly

CurrentEndo coverage · page 2 of 55

Diabetes, Obesity and Metabolism

Briefs 41–80 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease

    Meta-analysisComplications

  2. Diabetes Obes Metab

    Predicting the Long‐Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN ‐1 Trial

    Secondary analysisObesity

  3. Diabetes Obes Metab

    Chronic Kidney Disease Severity and Progression to Proliferative Diabetic Retinopathy

    Cohort studyComplications

  4. Diabetes Obes Metab

    Cost‐Effectiveness of a Culturally Adapted Diabetes Self‐Management Education Program for Marshallese Adults With Type 2 Diabetes‐a State‐Transition Markov Analysis

    Research articleT2D & other

  5. Diabetes Obes Metab

    Early Use of Automated Insulin Delivery With Telehealth Support in People Recently Diagnosed With Type 1 Diabetes: One‐Year Outcomes From a Prospective Observational Study

    Cohort studyTechnology

  6. Diabetes Obes Metab

    Effectiveness, Safety and Pharmacokinetics of BGM0504 , a Dual GLP ‐1/ GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double‐Blind, Placebo‐Controlled Trial

    Randomized controlled trialObesity

  7. Diabetes Obes Metab

    Efficacy and Safety of a Novel Reversible Gastric Bypass Stent System for Weight Loss: A Multicentre Real‐World Study

    Cohort studyObesity

  8. Diabetes Obes Metab

    Higher Cardiorespiratory Fitness Is Associated With a Lower Burden of Metabolic Syndrome Traits: A Cross‐Sectional Analysis of 39 197 UK Adults

    Cross-sectional studyT2D & other

  9. Diabetes Obes Metab

    Layered Effects of LDL ‐C Burden and Variability on Cardiovascular Events and Mortality in Type 2 Diabetes: A Nationwide Cohort Study

    Cohort studyT2D & other

  10. Diabetes Obes Metab

    Metabolic and Psychological Effects of Mylife CamAPS FX Hybrid Closed‐Loop Therapy in Adults With Type 1 Diabetes, Markedly Elevated HbA1c , and Psychological Vulnerability: The Hi‐Loop Randomised Clinical Trial

    Randomized controlled trialTechnology

  11. Diabetes Obes Metab

    Non‐Invasive Fibrosis Testing in Adults With Obesity and MASLD : A Systematic Review and Meta‐Analysis

    Meta-analysisLipids & liver

  12. Diabetes Obes Metab

    Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete‐Choice Experiment ( OPTIC )

    Cross-sectional studyObesity

  13. Diabetes Obes Metab

    Real‐World Adherence Trajectories of GLP ‐1 Receptor Agonists Among Adults and Paediatric Patients With Obesity

    Cohort studyObesity

  14. Diabetes Obes Metab

    Sensor‐Detected Hypoglycaemia Is Associated With Inflammatory Protein and Immune Cell Alterations in People With Diabetes: Findings From the Hypo‐ METRICS Study

    Cohort studyComplications

  15. Diabetes Obes Metab

    Managing Type 1 Diabetes in Neurodiverse Children and Young People: A Qualitative Exploration of Complexity and Care Challenges

    Research articleT1D

  16. Diabetes Obes Metab

    Fracture‐Centred Skeletal Reporting Profiles of Glucose‐Lowering Drug Classes in FAERS and JADER : Cross‐Database and Regional Reporting‐Context Analyses

    Cohort studyT2D & other

  17. Diabetes Obes Metab

    GLP ‐1 Receptor Agonist–Based Prandial Insulin De‐Intensification in Outpatients With Type 2 Diabetes Receiving Basal–Bolus Insulin Therapy or Multiple Daily Injections: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

    Meta-analysisT2D & other

  18. Diabetes Obes Metab

    Obesity and Midlife Performance: A Cross‐Sectional and Longitudinal Analysis of Women in the Menarche‐To‐ PreMenopause Study

    Cross-sectional studyObesity

  19. Diabetes Obes Metab

    Practical Guidance for the Use of Control‐ IQ Technology During Physical Activity and Exercise

    Guideline or statementTechnology

  20. Diabetes Obes Metab

    Psychiatric Safety of GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists in Adolescents With Obesity

    Cohort studyObesity

  21. Diabetes Obes Metab

    Real‐World Cost and Utilisation Burden of Diagnosed Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes in the United States: A Retrospective Cohort Study

    Cohort studyT2D & other

  22. Diabetes Obes Metab

    Sex‐Stratified Associations of DXA ‐Derived Adiposity, Regional Fat Distribution and Muscle Power With Incident Hospitalised Cardiovascular Disease in Older Adults: A Prospective Cohort Study

    Cohort studyLipids & liver

  23. Diabetes Obes Metab

    Short‐Term Changes in General and Central Adiposity and Subsequent Cardiometabolic Risk in Japanese Adults Undergoing Routine Health Screening

    Cohort studyLipids & liver

  24. Diabetes Obes Metab

    Total and Regional Fat‐to‐Muscle Ratio ( FMR ) and Risk of Osteoporosis: Evidence From the UK Biobank Cohort

    Cohort studyBone & mineral

  25. Diabetes Obes Metab

    Effects of Renin–Angiotensin Inhibitors, Sodium–Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon‐Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta‐Analysis

    Meta-analysisT1D

  26. Diabetes Obes Metab

    Longitudinal Metabolic Risk Factors Are Associated With Microvascular Complications

    Secondary analysisComplications

  27. Diabetes Obes Metab

    OGTT ‐Derived β‐Cell Function–Based Stratification of 2‐Year Glycaemic Transitions in Chinese Adults With Prediabetes

    Cohort studyT2D & other

  28. Diabetes Obes Metab

    Efficacy and Safety of Glucagon‐Like Peptide‐1 Receptor Agonists as Adjuncts to Insulin Therapy in Type 1 Diabetes Mellitus: An Overlap‐Informed Umbrella Review

    Meta-analysisT1D

  29. Diabetes Obes Metab

    The SGLT2i Treatment Gap in UK Primary Care: A Cross‐Sectional RWE Study of Prescribing in Clinical Practice

    Cross-sectional studyT2D & other

  30. Diabetes Obes Metab

    Alcohol Reduction and 15‐Year Cardiometabolic Changes in Glycemic, Lipid and Blood Pressure Profiles: A Target Trial Emulation Study

    Research articleT2D & other

  31. Diabetes Obes Metab

    Antenatal Corticosteroids in Gestational Diabetes: A Systematic Review of Glycemic Response and Management Strategies

    Meta-analysisDiabetes in pregnancy

  32. Diabetes Obes Metab

    Dose‐Normalised Time in Range ( dn‐TIR ) Improves Following Hybrid Closed‐Loop ( HCL ) Therapy in Type 1 Diabetes: A Real‐World Cohort Study From Australia and the United Kingdom

    Cohort studyTechnology

  33. Diabetes Obes Metab

    Renal Safety of Intravitreal Ranibizumab and the Effects of SGLT2 Inhibition in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial

    Secondary analysisComplications

  34. Diabetes Obes Metab

    Residual Apolipoprotein B Elevation Despite PREVENT ‐Guided LDL ‐C Goal Attainment Among Adults Without Known ASCVD

    Cross-sectional study

  35. Diabetes Obes Metab

    Additive Glucagonotropic and Insulinotropic Effects of Glucose‐Dependent Insulinotropic Polypeptide and Alanine in Fasted Healthy Men

    Randomized controlled trial

  36. Diabetes Obes Metab

    Association of GLP ‐1 Receptor Agonists Versus Other Antidiabetic Medications With Cardiovascular, Renal, and Liver Outcomes in Patients With Type 2 Diabetes

    Cohort studyT2D & other

  37. Diabetes Obes Metab

    Dual Energy X‐Ray Absorptiometry Reveals Differential Glycemic Implications of Adiposity in Underweight, Normal Weight, and Overweight South African Women With Newly‐Diagnosed Diabetes

    Cross-sectional studyObesity

  38. Diabetes Obes Metab

    Genome‐Wide Association Analyses Identify Distinct Genetic Architectures for Extreme Early‐Onset and Late‐Onset T2D

    Diagnostic or prognostic studyT2D & other

  39. Diabetes Obes Metab

    GLP ‐1 Receptor Agonists Post‐Bariatric Surgery ( GRABS ) Trial: Rationale, Design and Baseline Characteristics

    Randomized controlled trialObesity

  40. Diabetes Obes Metab

    Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study

    Cohort studyT2D & other

All 2,200 Briefs in ExploreShowing Briefs 41–80 of 2,200, newest first